Thermo Fisher ScientificRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Thermo Fisher ScientificLife-science tools group whose Patheon pharma services arm runs what the company calls the largest sterile fill-finish CDMO network. Acquired Sanofi's Ridgefield, NJ sterile fill-finish site in September 2025 and is investing about $1B across 60 CDMO sites in 2026, adding prefilled syringe, cartridge, and autoinjector assembly lines.
2021-Q2-2026-Q1
2021-Q2-2026-Q1
1994-2025
$TMO
Runs what the company calls the largest sterile fill-finish CDMO network, the step where GLP-1 supply has repeatedly bottlenecked. Bought Sanofi's Ridgefield, NJ sterile fill-finish site in September 2025 and is spending about $1B across 60 CDMO sites in 2026 on prefilled syringe, cartridge, and autoinjector assembly lines. The exposure is capacity, not peptide synthesis.